Research and Development Expense (Excluding Acquired in Process Cost)

Name: BioCryst Pharmaceuticals Research and Development Expense (Excluding Acquired in Process Cost) by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioCryst Pharmaceuticals·Products & Services·8 segments·Rolls up to R&D

Breakdown

Segment	Q1 '26
Compensation and related personnel costs	$27.09M
Navenibart	$9.74M
Other non-program specific and indirect costs	$7.42M
Research, discovery and preclinical programs	$3.97M
BCX17725	$1.91M
Berotralstat	$1.8M
Avoralstat	$893K
STAR-0310	$683K
Total	$60.32M

Segments

AvoralstatView metric

BCX17725View metric

BerotralstatView metric

Compensation and related personnel costsView metric

NavenibartView metric

Other non-program specific and indirect costsView metric

Research, discovery and preclinical programsView metric

STAR-0310View metric